As innovators change their product lifecycle management approach towards increased patient centricity, transitioning from intravenous (IV) infusion to SC administration with an injection device can be a huge game-changer (patient focus, compliance, differentiation from competitors), with notable examples being Herceptin (trastuzumab, Roche/Genentech), MabThera (rituximab, Roche/Genentech), Actemra (tocilizumab, Roche/Genentech), Benlysta (belimumab, GSK), Entyvio (vedolizumab, Takeda) and others
Vitamin C in Cancer: A Metabolomics Perspective Behboudi, L., et al
A Vitamin F blend of flaxseed, chia seed and macadamia seed oils replenishes skin's moisture barrier and protects it from environmental aggressors
Weight loss curves at the highest doses had not fully plateaued at the study endpoints, suggesting even greater losses with extended treatment
Do not extend the 28-day window to compensate, and do not leave it out again